Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study
Pharmacopsychiatry · 01.09.2025 · 58 (05) · 216-225
DOI: 10.1055/a-2479-9430 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Pharmacopsychiatry, erschienen am 01.09.2025. Verfasst von Tien-Wei Hsu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, E-Da Dachang Hospital, I-Shou University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Mood Disorders, Psychotropic Drugs. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
Background
This study aimed to assess the association between the risk of colorectal cancer (CRC) and exposure to mood stabilizers, antidepressants, and antipsychotics in patients with affective disorders.
Methods
This nested case-control study used data from the National Health Insurance Database of Taiwan collected between 2001 and 2011. All participants in this study had affective disorders. Then, 1209 patients with CRC and 1:10 matched controls were identified based on their demographic and clinical characteristics. A logistic regression model adjusted for demographic and clinical characteristics was used to determine the risk of developing CRC after exposure to psychotropic drugs.
Results
Among patients with affective disorders, exposure to mood stabilizers (reported as odds ratio; 95% confidence interval; 0.75; 0.57–0.98), antidepressants (0.83; 0.70–0.97), second-generation antipsychotics (0.67; 0.52–0.86), and first-generation antipsychotics (0.65; 0.52–0.81) were associated with a reduced risk of CRC compared to patients who were not exposed. When considering specific drugs, carbamazepine (0.34; 0.12–0.95), valproic acid (0.66; 0.46–0.95), gabapentin (0.44; 0.20–0.99), fluoxetine (0.82; 0.68–0.99), paroxetine (0.63; 0.45–0.87), and venlafaxine (0.72; 0.55–0.95) were associated with a lower risk of CRC.
Conclusion
Exposure to psychotropic drugs in patients with affective disorders is associated with a lower risk of CRC compared to those who were not exposed. Although the causal relationship between psychotropic drug exposure and reduced risk of CRC could not be inferred directly, these findings may help clinicians and patients in clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, E-Da Dachang Hospital, I-Shou University, Kaohsiung, Taiwan.
- Department of Psychiatry, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
- Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of Psychiatry, School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Family Medicine, Taipei Veterans General Hospital, Hsinchu Branch, Hsinchu, Taiwan.
- Institute of Hospital and Health Care Administration, National Yang-Ming University, Taipei, Taiwan.
ORCID-Profile: Mu-Hong Chen, Chih-Sung Liang
Zitieren
APA
Hsu, T. W., Tsai, S. J., Chen, T. J., Chen, M. H., & Liang, C. S. (2025). Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study. Pharmacopsychiatry, 58(05), 216-225. https://doi.org/10.1055/a-2479-9430
Vancouver
Hsu TW, Tsai SJ, Chen TJ, Chen MH, Liang CS. Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study. Pharmacopsychiatry. 2025;58(05):216-225. doi:10.1055/a-2479-9430
BibTeX
@article{Hsu2025,
author = {Hsu, Tien-Wei and Tsai, Shih-Jen and Chen, Tzeng-Ji and Chen, Mu-Hong and Liang, Chih-Sung},
title = {Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study},
journal = {Pharmacopsychiatry},
year = {2025},
volume = {58},
number = {05},
pages = {216--225},
doi = {10.1055/a-2479-9430}
}
EUVIMED